Publications

Showing 9 of 0 results

• ASH Annual Meeting

  November 2024

  A real-world analysis of the relationship between Epstein-Barr Virus positivity and baseline characteristics, treatment patterns and clinical outcomes in diffuse large B-cell lymphoma

  Yilmaz E, Wang W, Wadé N, et al.

  • Publication summary
  • Publications
  • Diffuse large B-Cell lymphoma

• ASH Annual Meeting

  November 2024

  Design and methodological considerations for real-world data-derived progression-free survival in Multiple Myeloma

  Wang J, Hayden J, Yue Y, et al.

  • Publication summary
  • Publications
  • Multiple myeloma

• ASH Annual Meeting

  November 2024

  The impact of structural racism and social determinants of health on fluorescence in situ hybridization testing among patients with multiple myeloma

  Pierre A, Ho G, Mbah O, Wang J, Ryals C;

  • Publication summary
  • Publications

• ASH Annual Meeting

  November 2024

  Real-world characteristics and survival outcomes of patients with Mantle Cell Lymphoma treated with covalent Bruton's tyrosine kinase inhibitors in first-line

  Sawas A, Wade N, Roose J

  • Publication summary
  • Publications

• ASH Annual Meeting

  November 2024

  Real-world outcomes of Acute Myeloid Leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2

  Espinoza-Gutarra M, Jarrett B, Wang X, Afghahi A, Bae S;

  • Publication summary
  • Publications

• ASH Annual Meeting

  November 2024

  Treatment patterns and predictors of survival after first line therapy in large B-Cell lymphoma in a real-world US cohort

  McGuirk J, Fessen M, Ramsey S, et al.

  • Publication summary
  • Publications

• ASH Annual Meeting

  November 2024

  Evaluating reasons for differences in real-world clinical outcomes among patients with relapsed/refractory Mantle Cell Lymphoma on covalent BTK inhibitors

  Phillips T, Mengyang D, Miller T, et al.

  • Publication summary
  • Publications

• JNCI Cancer Spectrum

  October 2024

  Mediators of racial/ethnic inequities in clinical trial participation among patients with cancer, 2011-2023

  Guadamuz J, Wang X, Altomare I, et al.

  • Clinical research
  • Publication summary
  • Publications
  • Health equity

• ISPOR Europe

  October 2024

  Is individual-patient data essential for transportability, or can aggregated data suffice?

  Mpofu P, Horne E, Pittell H, et al.

  • Real-world evidence
  • Publication summary
  • Publications